首页> 外国专利> PHARMACEUTICAL FORMULATIONS FOR PROLONGED DELIVERY OF ACTIVE (S) PRINCIPLE (S) AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS

PHARMACEUTICAL FORMULATIONS FOR PROLONGED DELIVERY OF ACTIVE (S) PRINCIPLE (S) AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS

机译:活性成分(S)长时间递送的药物配方及其特殊的治疗应用

摘要

The present invention concerns new pharmaceutical formulations based on aqueous colloidal suspensions for sustained release of active ingredient(s) - AI - in particular, protein(s) and peptide(s), as well as the applications, especially therapeutic, of these formulations. This formulation comprises an aqueous colloidal suspension with low viscosity based on micrometric particles of amphiphilic polymer PO that is biodegradable, hydrosoluble and carrying hydrophobic groups (HG) - alpha-tocopherol- and ionizable hydrophilic groups (IG) - Glu -, ionized at least in part, said particles being suitable for spontaneously combining non-covalently with an AI at pH = 7.0 under isotonic conditions; and with a size between 0.5 and 100 µm. This suspension contains multivalent ions (MgSUP++/SUP) with a polarity opposite that of IH groups of the PO, the ratio r fulfilling the formula (A) where - n is the valence of said multivalent ions - [MI] is the molar of multivalent ions, [IG] is the molar concentration of ionizable groups IG, is between 0.3 and 10.
机译:本发明涉及用于持续释放活性成分(AI),特别是蛋白质和肽的水性胶体悬浮液的新药物制剂,以及这些制剂的应用,特别是治疗性。该制剂包含基于两亲性聚合物PO的微米级颗粒的低粘度水性胶体悬浮液,该两性聚合物可生物降解,水溶性并带有疏水基团(HG)-α-生育酚和可电离的亲水基团(IG)-Glu-,至少在离子中被离子化部分,所述颗粒适合在等渗条件下与pH值为7.0的AI自发地非共价结合。尺寸在0.5到100 µm之间。该悬浮液包含极性与PO的IH基团相反的多价离子(Mg ++ ),比率r满足公式(A),其中-n是所述多价离子的化合价-[ MI]是多价离子的摩尔数,[IG]是可电离基团IG的摩尔浓度,在0.3和10之间。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号